Transaction DateRecipientSharesTypePriceValue
2nd October 2020Kerrii B Anderson11.34Grant/award etc.$688.84$7,811.45
25th September 2020Brian J Caveney289Payment by withholding$180.99$52,306.11
25th September 2020Brian J Caveney970Exercise of derivative$0.00
23rd September 2020Kerrii B Anderson3,500Grant/award etc.$0.00
27th August 2020Richelle P Parham7,474Grant/award etc.$0.00
10th August 2020Glenn A Eisenberg6,800Grant/award etc.$0.00
7th August 2020R Sanders Williams250Open or private sale$242.95$60,737.50
8th July 2020R Sanders Williams1,300Exercise of derivative$98.49$128,037.00
8th July 2020R Sanders Williams1,300Open or private sale$173.12$225,056.00
6th July 2020Kerrii B Anderson13.28Grant/award etc.$588.25$7,811.96
Laboratory Of America Holdings
Laboratory Of America Holdings logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 4/10.

Laboratory Corp. of America Holdings is a clinical laboratory company. The company engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments.

Ticker: LH
Sector: Health Services
Industry: Services to the Health Industry
SEC Central Index Key (CIK): 920148
Employees: 65000
Exchange: New York Stock Exchange
Auditor Opinion:

Disclosure Language changes
Red Flags
Cash at Carrying Value: $557 M (0%)
Inventory, Net: $342 M (39%)
Assets, Current: $3 B (14%)
Property, Plant and Equipment, Net: $3 B (0%)
Other Assets, Noncurrent: $431 M (0%)
Assets: $18 B (-1%)
Accounts Payable, Current: $534 M (-15%)
Accrued Liabilities, Current: $1 B (9%)
Liabilities, Current: $3 B (14%)
Long-term Debt, Excluding Current Maturities: $5 B (0%)
Other Liabilities, Noncurrent: $416 M (8%)
Liabilities: $10 B (0%)
Common Stock, Value, Issued: $9 M (0%)
Additional Paid in Capital, Common Stock: $32 M (19%)
Retained Earnings (Accumulated Deficit): $8 B (-1%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $449 M (0%)
Stockholders' Equity (Parent): $7 B (0%)
Liabilities and Equity: $18 B (-1%)
Gross Margin: $760 M (-48%)
Operating Income/Loss: $298 M (0%)
Other Income, net: $700 Th (-99%)
Provision for income taxes: $65 M (0%)
EPS (basic): $2.38 (0%)
EPS (diluted): $2.37 (0%)